Edesa Biotech, Inc.
EDSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001540159
No open-market purchases or sales by Edesa Biotech, Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $30.0M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Edesa Biotech, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- −3 vs. Q2 2022
- Shares held
- 539.7K
- −868.6K (−61.7%) vs. Q2 2022
- Total value
- $494.2K
- −$1.77M (−78.2%) vs. Q2 2022
- New holders
- 1
- 3 more added
- Sold out
- 4
- 2 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EDSA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 33 | $30.0M |
| Q1 2026 | 28 | $13.8M |
| Q4 2025 | 22 | $4.34M |
| Q3 2025 | 23 | $7.10M |
| Q2 2025 | 20 | $4.28M |
| Q1 2025 | 20 | $6.89M |
| Q4 2024 | 17 | $350.1K |
| Q3 2024 | 18 | $718.2K |
| Q2 2024 | 17 | $645.1K |
| Q1 2024 | 17 | $450.9K |
| Q4 2023 | 19 | $507.1K |
| Q3 2023 | 20 | $1.26M |
| Q2 2023 | 22 | $1.63M |
| Q1 2023 | 26 | $2.05M |
| Q4 2022 | 22 | $3.53M |
| Q3 2022 | 21 | $494.2K |
| Q2 2022 | 24 | $2.26M |
| Q1 2022 | 23 | $5.51M |
| Q4 2021 | 26 | $2.03M |
| Q3 2021 | 23 | $2.85M |
| Q2 2021 | 18 | $1.37M |
| Q1 2021 | 16 | $773.7K |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Edesa Biotech, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| CM Management, LLC | 250,000 | $230.0K | 0.26% | +250,000 | New |
| Vanguard Group Inc | 110,713 | $102.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 82,448 | $75.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 24,175 | $22.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 17,887 | $16.0K | 0.00% | −35,875−66.7% | Reduced |
| Dimensional Fund Advisors LP | 17,787 | $16.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 15,349 | $14.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 12,109 | $11.0K | 0.00% | +8,600+245.1% | Added |
| National Bank of Canada | 4,000 | $4.00K | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 1,000 | $1.10K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 1,191 | $1.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 1,431 | $1.00K | 0.00% | 00.0% | Unchanged |
| Fifth Third Bancorp | 700 | $1.00K | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 135 | $124 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 33 | $0 | 0.00% | −1,068−97.0% | Reduced |
| BlackRock Inc. | 518 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 75 | $0 | 0.00% | +4+5.6% | Added |
| Creative Financial Designs Inc | 23 | $0 | 0.00% | 00.0% | Unchanged |
| Credit Agricole S A | 9 | $0 | 0.00% | 00.0% | Unchanged |
| AllSquare Wealth Management LLC | 10 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 108 | $0 | 0.00% | +4+3.8% | Added |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −1,023,275−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −46,248−100.0% | Sold out |
| Merit Financial Group, LLC | 0 | $0 | 0.00% | −20,409−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −300−100.0% | Sold out |